Doktor axborotnomasi 2026, №2 (123)
Maqola mavzusi
CLINICAL VALUE OF CARDIOSPECIFIC BIOMARKERS IN THE DETECTION OF MYOCARDITIS IN CHILDREN WITH COMMUNITY-ACQUIRED PNEUMONIA (98-102)
Mualliflar
Sh. R. Odilova1, D. Yu. Akhmedova1, M. A. Urunova2, B. A. Tursunova2, M. R. Ortikova1
Muassasa
1Samarkand state medical university, Samarkand, 2The 2nd children's department of the SB of RSCEMC, Samarkand, Uzbekistan
Annotatsiya
The assessment of cardiac troponins occupies a leading position in modern cardiology, as these biomarkers reflect cardiomyocyte injury with high sensitivity and specificity [1,2]. In pediatric practice, the diagnostic value of cardiac biomarkers is of particular importance due to the difficulty of clinical diagnosis of myocardial involvement in infectious diseases [3]. The aim of the present study is to evaluate biomarkers of myocardial injury and identify the most diagnostically significant markers in children with community-acquired pneumonia complicated by myocarditis. The obtained results demonstrate that cardiac troponin I, α-hydroxybutyrate dehydrogenase (α-HBDH), and creatine kinase MB fraction (CK-MB) are reliable indicators of myocardial involvement in children with community-acquired pneumonia and can be used to assess disease severity and prognosis [4,5].
Kalit so'zlar
myocarditis, children, cardiac troponin I, community-acquired pneumonia, biomarkers.
Adabiyotlar
1. Thygesen K., Alpert J.S., Jaffe A.S. et al. Fourth Universal Definition of Myocardial Infarction. Circulation. 2018;138(20): e 618–e651. 2. Apple F.S., Collinson P.O. Analytical characteristics of high-sensitivity cardiac troponin assays. Clinical Chemis try. 2012;58(1):54–61. 3. Kliegman R.M., St. Geme J.W. Nelson Textbook of Pediatrics. 21st ed. Elsevier; 2020. 4. Caforio A.L.P., Pankuweit S., Arbustini E. et al. Current state of knowledge on myocarditis. European Heart Jour nal. 2013;34(33):2636–2648. 5. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Elsevier; 2019. 6. Esposito S., Principi N. Infectious myocarditis in children. Current Opinion in Infectious Diseases. 2017;30(3):287–293. 7. Cooper L.T. Myocarditis. New England Journal of Medicine. 2009;360(15):1526–1538. 8. Gordon A.M., Regnier M., Homsher E. Skeletal and cardiac muscle contractile activation. Physiological Reviews. 2000;80(2):853–924. 9. Wu A.H.B., Christenson R.H. Cardiac markers. Clinical Chimica Acta. 2013;420:65–71. 10. Vijlbrief D.C., Benders M.J. et al. Cardiac troponin T in neonates. Pediatrics. 2012;129(4):e987–e994. 11. Lipshultz S.E. et al. Cardiomyopathy in children. Circulation. 2019;140(1):e9–e68. 12. Kindermann I. et al. Update on myocarditis. Journal of the American College of Cardiology. 2012;59(9):779–792. 13. Schultheiss H.P., Kühl U., Cooper L.T. The management of myocarditis. European Heart Journal. 2011;32 (21):2616–2625. 14. Jaffe A.S. et al. Troponin standards. Circulation. 2000;102(11):1216–1220. 15. Ammirati E. et al. Acute myocarditis. Nature Reviews Cardiology. 2018;15(11):670–688. 16. Mair J. Cardiac troponins. Clinical Chimica Acta. 2016;461:72–81. 17. Adams J.E. et al. Cardiac enzyme markers. American Heart Journal. 1993;126(6):1322–1327. 18. Smith S.C. et al. Biomarkers in cardiac injury. Heart. 2015;101(5):356–361. 19. Friedrich M.G. Myocardial inflammation. Journal of the American College of Cardiology. 2009;53(17):1475 1487. 20. Biesbroek P.S. et al. Prognostic value of biomarkers in myocarditis. European Journal of Heart Failure. 2018;20 (5):777–785. 21. Newby L.K. et al. Troponin interpretation in children. Clinical Chemistry. 2019;65(12):1424–1431.